MAIA logo

MAIA MAIA Biotechnology, Inc.

New York Stock Exchange Arca · Biotechnology · Healthcare

$1.14
-0.16 (-12.31%)

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in …

Market Cap: $70.40Mwww.MAIABiotech.com

Price

No data yet.

Social Signal Score

55
5d
—
30d
70
1 mentions
—
60d
50
4 mentions
—
90d
44
10 mentions
—
news: 10

Revenue

$0.00
$0.00
Sep 2020Sep 2026

Analyst Estimates

FY2025
$-0.74
$-0.74–$-0.74
1 analysts
FY2026
$-0.48
$-0.48–$-0.48
1 analysts
FY2027
$1.13
$1.13–$1.13
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Vlad Vitoc
Sector
Healthcare
Industry
Biotechnology
Employees
13
Beta
0.30
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
-4.67
www.MAIABiotech.com